Gene expression profiling does not predict long-term risk of malignancy in heart transplant recipients
AlloMap scores in the first 1 or 2 years after HT were not predictive of long-term malignancy risk in our multicenter study.
Authors
- Rupesh Kshetri
- Serkan Bektur
- April A. Pottebaum (ORCID: https://orcid.org/0000-0003-4072-5121)
- Cliff Pruett
- J. S. Schilling
- Natasha Aleksova (ORCID: https://orcid.org/0000-0002-8845-7851)
- Sami Berihun
- Elena Deych
Institutions
- University of Iowa (US)
- Washington University in St. Louis (US)
- Toronto General Hospital (CA)
Publication Details
- Journal
- JHLT Open
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1016/j.jhlto.2026.100500
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00